Covered recipient · General Payments record
TARA STARR
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$6,629.03
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $737.97 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GLAUKOS CORPORATION | $202.16 | 1 |
| Amgen Inc. | $173.95 | 2 |
| Alcon Laboratories Inc | $134.07 | 1 |
| GlaxoSmithKline, LLC. | $121.83 | 1 |
| Tarsus Pharmaceuticals, Inc. | $68.25 | 3 |
| Oyster Point Pharma, Inc. | $23.17 | 1 |
| Sight Sciences, Inc. | $14.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alcon Vision LLC | $134.07 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110575329 | CMS |
| Amgen Inc. | $23.96 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116149275 | CMS |
| Amgen Inc. | $149.99 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116149282 | CMS |
| Glaukos Corporation | $202.16 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151993963 | CMS |
| GlaxoSmithKline, LLC. | $121.83 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116437775 | CMS |
| Oyster Point Pharma, Inc. | $23.17 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147421197 | CMS |
| Sight Sciences, Inc. | $14.54 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151931317 | CMS |
| Tarsus Pharmaceuticals, Inc. | $15.54 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139134296 | CMS |
| Tarsus Pharmaceuticals, Inc. | $25.87 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139134298 | CMS |
| Tarsus Pharmaceuticals, Inc. | $26.84 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139134300 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.